Carbon dioxide production during acetazolamide and medroxyprogesterone treatment.
Cole
R P
RP
D000086:Acetazolamide / Q000008:administration & dosage*; D002245:Carbon Dioxide / Q000097:blood*; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D006935:Hypercapnia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D000860:Hypoxia / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D010100:Oxygen / Q000097:blood; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012119:Respiration / Q000187:drug effects
D002257:Carbonic Anhydrase Inhibitors; D002245:Carbon Dioxide; D008525:Medroxyprogesterone; D000086:Acetazolamide; D010100:Oxygen